March 6, 2017
SELLAS Life Sciences Announces Updated Positive Phase 2 Data Reinforcing Meaningful Clinical Be...
Read More
October 21, 2016
SELLAS™ Life Sciences Announces Positive Interim Phase II Results from its WT1 Immunotherapeu...
Read More
December 18, 2015
DARZALEX® (daratumumab) Approved by U.S. FDA First Available Treatment for Multiple Myeloma
Read More
June 8, 2011
PARENT COMMENTS ON REUTERS REPORT – U.S. cancer drugs shortage has doctors scrambling
Read More